Treatment outcomes of unruptured arteriovenous malformations with a subgroup analysis of ARUBA (A Randomized Trial of Unruptured Brain Arteriovenous Malformations)-eligible patients.

@article{Nerva2015TreatmentOO,
  title={Treatment outcomes of unruptured arteriovenous malformations with a subgroup analysis of ARUBA (A Randomized Trial of Unruptured Brain Arteriovenous Malformations)-eligible patients.},
  author={John D. Nerva and Alessandra Mantovani and Jason K. Barber and Louis J. Kim and Jason K. Rockhill and Danial K. Hallam and Basavaraj V. Ghodke and Laligam N. Sekhar},
  journal={Neurosurgery},
  year={2015},
  volume={76 5},
  pages={563-70; discussion570; quiz 570}
}
BACKGROUND The design and conclusions of A Randomized Trial of Unruptured Brain Arteriovenous Malformations (ARUBA) trial are controversial, and its structure limits analysis of patients who could potentially benefit from treatment. OBJECTIVE To analyze the results of a consecutive series of patients with unruptured brain arteriovenous malformations (BAVMs), including a subgroup analysis of ARUBA-eligible patients. METHODS One hundred five patients with unruptured BAVMs were treated over an… CONTINUE READING
17 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 17 extracted citations

Similar Papers

Loading similar papers…